52w high/low | ₹81.9 / ₹24.25 |
P/E ratio | -4.94 |
Dividend | 0 |
ROE | 3431.8 |
ROCE | -48.7 |
Face value | 10 |
Book value | ₹-2.16Cr |
Market capital | ₹16.84Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Incorporated as a public limited company in Nov.'94, Parmax Pharma (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. PPL set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 tpa. Its Antibiotic project has been fully implemented from 31st May'97, and the non-Antibiotic products project is under final stage of implementation.